Background {#Sec1}
==========

Self-rated health (SRH), a common but comprehensive measure of a person's global (physical and mental) health status, has been widely used to describe the health status of an individual and a population in epidemiology surveys because of the easily collected data \[[@CR1]\]. Respondents are asked to rate their own health status and there are three types of SRH that are frequently assessed in different studies. The most commonly used one is global SRH, in which respondents are requested to rate their current overall health status on a four- or five-point scale ranging from "very good (excellent)" to "very poor" \[[@CR2]\]. In the age-comparative SRH, respondents are asked to rate their health status as better, the same, or worse compared with other people of their ages \[[@CR3]\]. As for time-comparative SRH, respondents are asked to compare their present health to the health status a year earlier \[[@CR4]\]. SRH is one of the indicators recommended for health monitoring by the World Health Organization \[[@CR5]\], and has been demonstrated to be a powerful predictor of morbidity and mortality in different populations \[[@CR2], [@CR6], [@CR7]\].

Understanding the determinants and correlates of SRH can help public health professionals prioritize the interventions for health promotion and disease prevention. Previous studies have found a wide range of determinants of SRH, including sociodemographic factors, lifestyle factors, physical illness and psychological factors \[[@CR8]--[@CR12]\]. It is widely acknowledged that physical and mental illnesses are major determinants of SRH; however, few studies have comprehensively examined the relations of multiple physical and mental conditions with SRH. Many studies combined various physical illnesses into one variable to explore the association between the presence and/or number of chronic diseases and SRH \[[@CR9], [@CR13]--[@CR16]\]. A few studies examined different chronic diseases as independent variables, but the number of diseases was limited and generally less than eight \[[@CR17]--[@CR20]\]. Only one study conducted in western Sweden has examined eleven chronic diseases and their associations with SRH, but only global SRH was used and the sample size was small (*n* = 6061) \[[@CR21]\].

Using data from the China Kadoorie Biobank (CKB) with over half million participants, we aimed to investigate the relations of multiple comorbidities with global SRH and age-comparative SRH among middle-aged and elderly population in China.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

The CKB study is a general population-based prospective cohort study that was designed to investigate the complex interplay of lifestyle behavior, environmental and genetic factors and risks of various chronic diseases. The detailed study design, sampling strategy and features of the study participants are previously reported \[[@CR22], [@CR23]\]. In brief, a total of 512,891 participants aged from 30 to79 years old were recruited from ten regions covering five rural areas (Gansu, Henan, Zhejiang, Sichuan, and Hunan provinces) and five urban cities (Harbin, Qingdao, Suzhou, Liuzhou, and Haikou) in China between 2004 and 2008. The study sites were selected based on population stability, geographic area, quality of death and disease registries, regional patterns of diseases and exposure to specific risk factors, and local commitment and capacity.

In the baseline survey, trained interviewers conducted a standardized questionnaire using a laptop-based direct data-entry system for the questionnaires, with built-in functions to avoid data missing and logical errors. The questionnaires covered general demographic characteristics, socio-economic status, diet, general health, physical activity, family medical history and mental health. After the interview, a series of physical measurements including weight, height, waist and hip circumference and blood pressures were recorded for each participant by trained technicians, and a 10-mL non-fasting blood sample was taken.

We excluded 2 participants with missing values of body weight or height. A total of 512,889 participants (40.99% male and 59.01% female) remained in the current analysis.

Exposure variables {#Sec4}
------------------

Physician diagnosed disease status was enquired in baseline questionnaire. Respondents were asked: "Has a doctor ever told you that you had the following disease?" followed by a list of diseases including diabetes, hypertension, coronary heart disease (CHD), stroke, rheumatic heart disease, tuberculosis, emphysema/bronchitis, asthma, cirrhosis/chronic hepatitis, peptic ulcer, gallstone/gallbladder disease, kidney disease, fracture, rheumatic arthritis, psychiatric disorders, neurasthenia, head injury and cancer. If someone reported that he/she was diagnosed with cancer, the site of cancer was also asked. Prevalent diabetes was defined if the participant met one of the following criteria \[[@CR24]\]: 1) self-reported diagnosis of diabetes mellitus; 2) use of anti-diabetic medications; 3) fasting plasma glucose ≥7.0 mmol/L; and 4) random blood glucose ≥11.1 mmol/L. Prevalent hypertension was defined if the participants met one of the following criteria \[[@CR25]\]: 1) systolic blood pressure of ≥140 mmHg; 2) diastolic blood pressure of ≥90 mmHg; 3) self-reported diagnosis of hypertension; and 4) use of antihypertensive medication. If someone reported that he/she had been diagnosed with a disease, the age at first diagnosis and basic treatment information was also asked. Past year major depression was assessed using the Chinese version of computerized Composite International Diagnostic Inventory --- short form (CIDI-SF), and the details were described elsewhere \[[@CR26]\].

Outcome variables {#Sec5}
-----------------

To assess SRH status of each participant, two questions were asked in baseline interview: 1) How is your current general health status: excellent, good, fair, or poor? 2) How is your current health status compared with someone of your own age: better, about the same, worse, or don't know? We considered the first question as global SRH and the second one as age-comparative SRH. No data were missing for two SRH variables. We categorized the global SRH into two categories to be comparable to the literature on this topic: good (excellent, good) and poor (fair, poor). For the age-comparative SRH, participants answering "don't know" (*n* = 15,691, 3.06%) were excluded from the analysis. To be consistent with global SRH, participants answering "about the same" (*n* = 321,218, 62.63%) were excluded in the main analysis and thus age-comparative SRH was categorized into two groups: better and worse. In order to ensure the accuracy and robustness of the results, we also conducted sensitivity analysis of including participants who reported "about the same" and thus age-comparative SRH was categorized into three groups: better, about the same, and worse.

Confounding factors {#Sec6}
-------------------

Other variables included age, sex, study location (10 regions), marital status (married, widowed, separated/divorced, never married), education level (no formal education, primary, middle or high school, college/university or higher), annual household income (\< 10,000, 10,000--19,999, 20,000--34,999, ≥35,000 RMB), employment status (employed, unemployed and retired), cigarette smoking (never, former, occasionally, current smoker) and alcohol drinking (never, former, occasionally, current drinker) were also inquired in the baseline questionnaires. Body mass index (BMI) was calculated as weight divided by the square of height (kg/m^2^). The physical activity level was measured by adding up metabolic equivalent tasks (METs) for daily work or leisure activities. All participants were also inquired about their family history of five diseases, including diabetes, heart attack, stroke, mental disorders and cancer.

Statistical analysis {#Sec7}
--------------------

Baseline demographic, socioeconomic, behavioral characteristics by global SRH categories and age-comparative SRH groups were presented by unadjusted proportions for categorical variables and unadjusted means with standard deviations (SD) for continuous variables, and compared using ANOVA and Chi-square tests for continuous and categorical variables, respectively. Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for relations of multiple comorbidities with global and age-comparative SRH. We adjusted for potential confounders in sequential steps: model 1 adjusted for sociodemographic factors (age in continuous variable, sex, study location, marital status, education level, household income and occupation in categorical variable); model 2 further adjusted for lifestyle factors (BMI in continuous variable, cigarette smoking, alcohol drinking, physical activity level and family history of five diseases, in categories); model 3 additionally adjusted for all comorbidities in the same model to test the independent associations. In the sensitivity analysis of including participants answering "about the same" for the age-comparative SRH, multinomial logistic regression models were used.

Population attributable risks (PARs) were used to estimate the proportion of the total prevalence of poor global SRH (or worse age-comparative SRH) that could be attributed to multiple comorbidities, and were calculated for each disease using the following formula: PAR=(p(OR-1))/(p(OR-1)+1) \[[@CR27]\], where p denotes the proportion of participants with the condition in the study population, and OR is the corresponding odds ratio observed in our study.

Stratified analyses were performed according to sex, administrative regions (urban and rural), age (30--59, ≥60 years old), education level (no formal education, primary school, middle school or higher) and household income (\< 10,000, 10,000--34,999 and ≥ 35,000 RMB). Tests for interaction were conducted by adding interaction terms of the certain disease and the stratifying variable in the final model. We also analyzed the impact of the duration of disease diagnosis, treatment, the number of diseases and the site of cancer on global and age-comparative SRH. Furthermore, to test the influence of undiagnosed diseases on the associations, we used hypertension and diabetes as examples in a sensitivity analysis. In the main analysis, the definitions of hypertension and diabetes included both the self-reported physician-diagnosed diseases and screening-detected diseases from the physical examination (which could be considered as undiagnosed cases). In the sensitivity analysis, we only used self-reported physician-diagnosed hypertension and diabetes (yes vs. no) as the exposures and evaluated their associations with SRH. All analyses were performed using SAS 9.3 (SAS Institute Inc), and two-sided *P* values \< 0.05 were considered as statistical significance.

Results {#Sec8}
=======

The baseline characteristics of participants are presented in Table [1](#Tab1){ref-type="table"}. Of the 512,889 participants, the mean age (standard deviation, SD) was 51.53 (10.68), and 59.01% (*n* = 302,631) were women. Most participants were married (90.59%) and more than half (55.90%) were recruited from rural areas; two-thirds of the participants were employed (68.74%), and about one-fourth (26.43%) were current smokers and 17.13% were current regular drinkers. The mean (SD) MET and BMI of the participants was 21.08 (13.87) and 23.66 (3.38), respectively.Table 1Characteristics of the study participants by self-rated health status^a^VariableTotal\
(*n* = 512,889)Global Self-rated HealthAge-comparative Self-rated HealthGood\
(*n* = 234,699)Fair/Poor\
(*n* = 278,190)*P* Value^b^Better\
(*n* = 93,235)Same (n = 321,218)Worse\
(*n* = 82,745)*P* Value^b^Age, mean (SD), y51.53 (10.68)50.27 (10.43)52.59 (10.77)\< 0.00151.14 (10.78)51.27 (10.60)52.45 (10.67)\< 0.001Female gender302,631 (59.01)131,178 (55.89)171,453 (61.63)\< 0.00150,321 (53.97)188,751 (58.76)53,568 (64.74)\< 0.001Physical activity, mean (SD), MET h/wk21.08 (13.87)22.89 (14.18)19.55 (13.42)\< 0.00121.60 (13.73)21.60 (13.97)19.08 (13.58)\< 0.001BMI, mean (SD)23.66 (3.38)23.76 (3.24)23.57 (3.49)\< 0.00124.06 (3.22)23.59 (3.32)23.52 (3.73)\< 0.001Rural residence286,703 (55.90)129,793 (55.30)156,910 (56.40)\< 0.00141,771 (44.80)193,272 (60.17)46,787 (56.64)\< 0.001Married currently464,607 (90.59)216,143 (92.09)248,464 (89.31)\< 0.00184,713 (90.86)292,908 (91.19)73,271 (88.55)\< 0.001Educational level^d^\< 0.001\< 0.001 No formal school95,220 (18.57)42,999 (18.32)52,221 (18.77)13,235 (14.20)59,244 (18.44)19,440 (23.49) Primary School165,216 (32.21)70,612 (30.09)94,604 (34.01)24,664 (26.45)108,479 (33.77)27,045 (32.68) Middle or high School222,439 (43.37)105,233 (44.84)117,206 (42.13)46,579 (49.96)136,627 (42.53)32,654 (39.46) College or university30,014 (5.85)15,855 (6.76)14,159 (5.09)8757 (9.39)16,868 (5.25)3606 (4.36)Annual income, Chinese Yuan^d^\< 0.001\< 0.001 0--9999144,832 (28.24)56,688 (24.15)88,144 (31.68)25,112 (26.93)83,500 (25.99)32,365 (39.11) 10,000--19,999149,013 (29.05)64,685 (27.56)84,328 (30.31)26,804 (28.75)94,432 (29.40)23,573 (28.49) 20,000--34,999126,719 (24.71)62,152 (26.48)64,567 (23.21)22,374 (24.00)84,697 (26.37)16,195 (19.57) \> 35,00092,325 (18.00)51,174 (21.80)41,151 (14.79)18,945 (20.32)58,589 (18.24)10,612 (12.82)Employment status\< 0.001\< 0.001 Retired84,939 (16.56)33,170 (14.13)51,769 (18.61)17,709 (18.99)49,313 (15.35)13,997 (16.92) Employed352,574 (68.74)173,032 (73.73)179,542 (64.54)65,553 (70.31)226,383 (70.48)52,381 (63.30) Unemployed75,376 (14.70)28,497 (12.14)46,879 (16.85)9973 (10.70)45,522 (14.17)16,367 (19.78)Current smoker135,554 (26.43)67,957 (28.95)67,597 (24.30)\< 0.00127,937 (29.96)85,405 (26.59)18,733 (22.64)\< 0.001Current alcohol drinker87,847 (17.13)46,470 (19.80)41,377 (14.87)\< 0.00121,328 (22.88)53,474 (16.65)10,975 (13.26)\< 0.001Family history of five diseases^c^197,147 (38.44)89,283 (45.29)107,864 (54.71)\< 0.00139,772 (42.66)116,535 (36.28)35,936 (43.43)\< 0.001Cardiometabolic diseases Coronary heart disease15,472 (3.02)3181 (1.36)12,291 (4.42)\< 0.0011605 (1.72)7622 (2.37)5861 (7.08)\< 0.001 Rheumatic heart disease938 (0.18)152 (0.06)786 (0.28)\< 0.00169 (0.07)361 (0.11)482 (0.58)\< 0.001 Stroke8884 (1.73)1612 (0.69)7272 (2.61)\< 0.001723 (0.78)3608 (1.12)4312 (5.21)\< 0.001 Hypertension174,480 (34.02)72,583 (30.93)101,897 (36.63)\< 0.00128,007 (30.34)108,330 (33.72)32,531 (39.31)\< 0.001 Diabetes30,300(5.91)9159(3.90)21,141(7.60)\< 0.0013709(3.98)16,453(5.12)9018(10.90)\< 0.001Respiratory diseases Tuberculosis7660 (1.49)2535 (1.08)5125 (1.84)\< 0.0011255 (1.35)4209 (1.31)1996 (2.41)\< 0.001 Emphysema/bronchitis13,289 (2.59)3242 (1.38)10,047 (3.61)\< 0.0011291 (1.38)6276 (1.95)5233 (6.32)\< 0.001 Asthma2806 (0.55)695 (0.30)2111 (0.76)\< 0.001278 (0.30)1322 (0.41)1127 (1.36)\< 0.001Musculoskeletal diseases Fracture35,448 (6.91)16,416 (6.99)19,032 (6.84)0.03126711 (7.20)21,213 (6.60)6377 (7.71)\< 0.001 Rheumatoid arthritis10,626 (2.07)2928 (1.25)7698 (2.77)\< 0.0011312 (1.41)5318 (1.66)3467 (4.19)\< 0.001Mental diseases Depressive symptoms3281 (0.64)704 (0.30)2577 (0.93)\< 0.001319 (0.34)1375 (0.43)1502 (1.82)\< 0.001 Psychiatric disorders1906 (0.37)512 (0.22)1394 (0.50)\< 0.001145 (0.16)868 (0.27)815 (0.98)\< 0.001 Neurasthenia5699 (1.11)1503 (0.64)4196 (1.51)\< 0.001673 (0.72)2702 (0.84)2208 (2.67)\< 0.001Digestive diseases Cirrhosis/chronic hepatitis6195 (1.21)2098 (0.89)4097 (1.47)\< 0.001680 (0.73)3499 (1.09)1707 (2.06)\< 0.001 Peptic ulcer20,017 (3.90)6666 (2.84)13,351 (4.80)\< 0.0012869 (3.08)10,818 (3.37)5610 (6.78)\< 0.001 Gallstone/gallbladder disease31,001 (6.04)10,862 (4.63)20,139 (7.24)\< 0.0014327 (4.64)17,064 (5.31)8685 (10.50)\< 0.001Cancer2577 (0.50)567 (0.24)2010 (0.72)\< 0.001217 (0.23)1112 (0.35)1174 (1.42)\< 0.001Other diseases Kidney disease7577 (1.48)2401 (1.02)5176 (1.86)\< 0.0011133 (1.22)3664 (1.14)2574 (3.11)\< 0.001 Head injury5653 (1.10)2335 (0.99)3318 (1.19)\< 0.0011029 (1.10)3182 (0.99)1272 (1.54)\< 0.001*Abbreviations*: *BMI* body mass index, *MET* metabolic equivalent^a^Data are presented as frequency (percentage) unless otherwise indicated^b^Two-sided *P* values were derived from ANOVA for continuous variables and Chi-square test for categorical variables^c^Including family history of diabetes, heart attack, stroke, mental disorders and cancer^d^The percentages may not add up to 100% because of rounding

The most prevalent disease was hypertension (34.02%), followed by fracture (6.91%), gallstone/gallbladder disease (6.04%), diabetes (5.91%), peptic ulcer (3.90%), CHD (3.02%), emphysema/bronchitis (2.59%), rheumatoid arthritis (2.07%), stroke (1.73%), cirrhosis/chronic hepatitis (1.21%), tuberculosis (1.49%), kidney disease (1.48%), neurasthenia (1.11%), head injury (1.10%), depressive symptoms (0.64%), asthma (0.55%), cancer (0.50%), psychiatric disorders (0.37%) and rheumatic heart disease (0.18%) (Table [1](#Tab1){ref-type="table"}).

Table [2](#Tab2){ref-type="table"} shows the associations between various diseases and global SRH. In the final multivariate model, suffering from any of the diseases increased the chance of reporting a poor global SRH, the OR (95% CI) ranged from 1.10 (1.07, 1.13) for fracture to 3.21 (2.68, 3.83) for rheumatic heart disease. Similar findings were obtained in the stratified analyses, while the magnitude of the association between some diseases and global SRH was significantly stronger in one stratum than the other ([Appendix](#Sec11){ref-type="sec"} Tables 5--7).Table 2Multiple comorbidities associated with global self-rated health statusModel 1^a^Model 2^b^Model 3^c^OR95% CIOR95% CIOR95% CICardiometabolic diseases Coronary heart disease2.912.79, 3.032.872.75, 2.992.542.43, 2.65 Rheumatic heart disease3.743.14, 4.463.593.01, 4.283.212.68, 3.83 Stroke3.303.12, 3.493.102.93, 3.282.912.74, 3.07 Hypertension1.241.22, 1.261.281.26, 1.291.251.23, 1.26 Diabetes1.861.81, 1.911.851.80, 1.891.771.72, 1.82Respiratory diseases Tuberculosis1.581.50, 1.661.541.46, 1.611.481.41, 1.56 Emphysema/bronchitis2.652.55, 2.772.572.46, 2.672.472.37, 2.58 Asthma2.552.33, 2.782.482.27, 2.712.051.87, 2.24Musculoskeletal diseases Fracture1.111.08, 1.141.121.09, 1.151.101.07, 1.13 Rheumatoid arthritis1.991.90, 2.081.991.90, 2.081.831.75, 1.92Mental disease Depressive Symptoms3.092.83, 3.363.012.76, 3.282.662.44, 2.90 Psychiatric disorders2.522.27, 2.792.452.20, 2.712.161.94, 2.40 Neurasthenia2.522.37, 2.672.472.33, 2.632.142.01, 2.27Digestive diseases Cirrhosis/chronic hepatitis1.801.71, 1.901.721.63, 1.821.671.58, 1.77 Peptic ulcer1.781.72, 1.831.721.67, 1.781.691.64, 1.75 Gallstone/gallbladder disease1.691.65, 1.731.681.63, 1.721.591.55, 1.64Cancer2.652.41, 2.912.432.21, 2.672.562.33, 2.82Other diseases Kidney disease1.811.72, 1.901.781.70, 1.881.631.55, 1.72 Head injury1.231.17, 1.301.241.17, 1.311.191.12, 1.26*Abbreviations*: *CI* confidence intervals, *OR* odds ratio^a^Model 1: adjusted for age, sex, study location, marital status, education level, income and occupation^b^Model 2: model 1 plus cigarette smoking, alcohol drinking, physical activity, BMI and family history of five disease (stroke, heart attack, diabetes, mental disorders and cancer)^c^Model 3: model 2 plus all comorbidities in the same mode

Table [3](#Tab3){ref-type="table"} shows the associations between various diseases and age-comparative SRH. In the final multivariate model, similarly, all diseases were associated with higher odds of a worse age-comparative SRH: the OR (95% CI) ranged from 1.18 (1.13, 1.23) for fracture to 7.56 (6.93, 8.25) for stroke. Similar findings were obtained in the stratified analyses ([Appendix](#Sec11){ref-type="sec"} Tables 8--10). Stroke remained to have the strongest association in certain subgroups (rural residence, male, age subgroups, all education levels and low household income groups). In the sensitivity analysis of including participants who answered "about the same", the results did not change materially either using better as the reference group ([Appendix](#Sec11){ref-type="sec"} Tables 11) or using "about the same" as the reference group ([Appendix](#Sec11){ref-type="sec"} Tables 12): people with multiple comorbidities were less likely to report better age-comparative SRH while more likely to report worse age-comparative SRH.Table 3Multiple comorbidities associated with age-comparative self-rated health status^a^Model 1^b^Model 2^c^Model 3^d^OR95% CIOR95% CIOR95% CICardiometabolic diseases Coronary heart disease5.214.91, 5.535.234.93, 5.564.484.21, 4.78 Rheumatic heart disease6.845.29, 8.836.354.91, 8.226.174.72, 8.06 Stroke8.067.43, 8.757.406.81, 8.047.566.93, 8.25 Hypertension1.461.43, 1.491.571.54, 1.611.471.44, 1.51 Diabetes3.122.99, 3.253.122.99, 3.253.032.89, 3.16Respiratory diseases Tuberculosis2.061.91, 2.211.931.79, 2.081.871.73, 2.03 Emphysema/bronchitis4.504.22, 4.794.213.95, 4.494.273.99, 4.57 Asthma4.794.18, 5.484.533.95, 5.193.603.11, 4.17Musculoskeletal diseases Fracture1.171.13, 1.221.211.17, 1.261.181.13, 1.23 Rheumatoid arthritis2.902.72, 3.102.952.76, 3.162.672.49, 2.87Mental diseases Depressive Symptoms4.654.11, 5.274.523.98, 5.123.853.37, 4.39 Psychiatric disorders5.734.78, 6.865.454.55, 6.544.834.00, 5.83 Neurasthenia4.083.73, 4.463.993.65, 4.373.222.92, 3.54Digestive diseases Cirrhosis/chronic hepatitis3.022.75, 3.312.772.52, 3.042.732.47, 3.01 Peptic ulcer2.572.45, 2.702.442.33, 2.572.472.35, 2.60 Gallstone/gallbladder disease2.362.26, 2.452.342.25, 2.442.182.09, 2.27Cancer6.095.25, 7.075.174.45, 6.016.465.54, 7.54Other diseases Kidney disease2.652.46, 2.862.602.41, 2.802.292.12, 2.48 Head injury1.561.43, 1.701.601.47, 1.751.521.38, 1.67*Abbreviations*: *CI* confidence intervals, *OR* odds ratio^a^Participants answering "don't know" (n = 15,691) and "about the same" (n = 321,218) for the age-comparative self-rated health status question were excluded from the analysis, leaving 175,980 participants in this analysis^b^Model 1: adjusted for age, sex, study location, marital status, education level, income and occupation^c^Model 2: model 1 plus cigarette smoking, alcohol drinking, physical activity, BMI and family history of five disease (stroke, heart attack, diabetes, mental disorders and cancer)^d^Model 3: model 2 plus all comorbidities in the same model

From the population perspective, cardiometabolic diseases (hypertension, diabetes, CHD, and stroke), explained the largest part of poor global SRH and worse age-comparative SRH in our study population, followed by emphysema/bronchitis and gallstone/gallbladder disease. Whereas the contribution of rheumatic heart diseases, psychiatric disorders and cancer was small because of the low prevalence (Table [4](#Tab4){ref-type="table"}).Table 4Population attributable risks for poor self-rated health by multiple comorbidities^a^Global SRH (Total *n* = 512,889)Age-comparative SRH (Total *n* = 175,980)PAR95% CIPAR95% CICardiometabolic diseases Coronary heart disease4.444.14, 4.759.518.84, 10.25 Rheumatic heart disease0.400.30, 0.510.920.67, 1.25 Stroke3.202.92, 3.4610.199.30, 11.14 Hypertension7.847.26, 8.1313.7913.02, 14.78 Diabetes4.354.08, 4.6210.7110.05, 11.32Respiratory diseases Tuberculosis0.710.61, 0.831.281.08, 1.51 Emphysema/bronchitis3.673.43, 3.937.817.19, 8.46 Asthma0.570.48, 0.681.411.15, 1.71Musculoskeletal diseases Fracture0.690.48, 0.891.230.89, 1.56 Rheumatoid arthritis1.691.53, 1.873.342.99, 3.73Mental diseases Depressive Symptoms1.050.91, 1.201.791.49, 2.12 Psychiatric disorders0.430.35, 0.521.401.10, 1.76 Neurasthenia1.251.11, 1.392.402.09, 2.74Digestive diseases Cirrhosis/chronic hepatitis0.800.70, 0.922.051.75, 2.37 Peptic ulcer2.622.44, 2.845.425.00, 5.87 Gallstone/gallbladder disease3.443.22, 3.726.656.18, 7.12Cancer0.770.66, 0.902.662.22, 3.17Other diseases Kidney disease0.920.81, 1.051.871.63, 2.14 Head injury0.210.13, 0.290.570.42, 0.73*Abbreviations*: *CI* confidence intervals, *PAR* population attributable risks^a^Note that the prevalences of these diseases and symptoms overlap and therefore the population attributable risks cannot be summed up but should be considered as relative

We further examined whether treatment would affect SRH, the results suggested that people with diseases and still on treatment tended to report a poor global SRH and worse age-comparative SRH compared with those having a disease but not receiving treatment ([Appendix](#Sec11){ref-type="sec"} Table 13). For diabetes and hypertension, shorter duration was associated with less worse SRH, while for other diseases, longer duration was associated with a much worse global and age-comparative SRH ([Appendix](#Sec11){ref-type="sec"} Table 14). Compared with people without any diseases, the OR for poor global SRH was 1.44 for having one disease, 2.37 and 3.91 for two and three diseases, respectively, and 6.45 when four or more diseases were present (*P* for trend \< 0.001; [Appendix](#Sec11){ref-type="sec"} Table 15). For worse age-comparative SRH, the corresponding OR was 2.13, 5.15, 10.50, and 20.39 for one, two, three and four or more diseases (*P* for trend \< 0.001; [Appendix](#Sec11){ref-type="sec"} Table 15).

When looking at different types of cancer, liver cancer had the greatest impact on global SRH (OR: 3.85; 95% CI: 1.48, 10.01), followed by lung cancer, stomach cancer, other cancer types, intestine cancer, breast cancer, cervix cancer and esophagus cancer. For age-comparative SRH, esophagus cancer had the greatest impact (OR: 8.94; 95% CI: 5.43, 14.74), followed by lung cancer, stomach cancer, other cancer types, liver cancer, breast cancer, intestine cancer and cervix cancer ([Appendix](#Sec11){ref-type="sec"} Table 16).

When examining the influence of undiagnosed diseases on the association, we found that the association become stronger in the sensitivity analysis of using self-reported hypertension and diabetes compared to the main analysis of using both self-reported and screening-detected (i.e., undiagnosed) hypertension and diabetes ([Appendix](#Sec11){ref-type="sec"} Table 17).

Discussion {#Sec9}
==========

In this large population-based prospective study, we found that having multiple diseases significantly increased the chance of reporting a poor global SRH and a worse age-comparative SRH, although the magnitude of different diseases varied substantially. We also found cardiometabolic diseases (hypertension, diabetes, CHD and stroke) had the strongest impact on both global SRH and age-comparative SRH at the population level.

Overall, presence of cardiovascular disease (CHD, stroke and rheumatic heart disease) had the biggest impact on global SRH. Other diseases that have a great impact on global SRH including respiratory disease (emphysema/bronchitis and asthma), mental disorders and cancer (adjusted ORs were all above 2.00). Consistent with our findings, Haseli-Mashhadi et al. \[[@CR20]\] found that cardiovascular disease had the strongest impact on global SRH in a study of 3289 middle-aged and elderly Chinese adults. Some other studies in different populations also found that cardiovascular disease, cancer and mental diseases were the major determinants of global SRH \[[@CR19], [@CR21], [@CR28], [@CR29]\].

In general, the associations between diseases and age-comparative SRH were stronger than the associations with global SRH. Consistently, cardiovascular disease, cancer and mental diseases had the major impact on reporting worse age-comparative SRH. Our findings are consistent with some other studies which found that chronic diseases substantially affected people's perception of their health status compared to their peers of similar age. In our study, stroke was the most important factor affecting age-comparative SRH among total population, rural residence and male participants. A study in Sweden also found that stroke had the biggest impact on reporting worse age-comparative SRH \[[@CR18]\], while a study in Hong Kong found that depressive symptoms was the most significant factor associated with worse age-comparative SRH \[[@CR17]\].

Chronic disease like CHD, stroke, rheumatic heart disease, cancer, and emphysema or bronchitis have a great influence on people's functional ability, which in turn is significantly associated with both global and age-comparative SRH \[[@CR3], [@CR15], [@CR17]\]. Meanwhile, people with chronic diseases can experience pain and disability that results in poor SRH. Depression was another important factor affecting both global and age-comparative SRH in our study: people who are more depressed are more inclined to rate their health more negatively, which is consistent with previous studies \[[@CR30]--[@CR32]\].

In our population of middle-aged and elderly men and women, hypertension had the strongest impact on both global SRH and age-comparative SRH at the population level. The contributions of diabetes, CHD and stroke to the burden of poor global SRH and worse age- comparative SRH were also large due to either high prevalence rates or large effect size. However, it should be noted that the population level contribution of different diseases may vary in populations with different prevalence rates.

We found that people with diseases and still on treatment generally reported worse SRH compared to those with a disease but not receiving treatment, which might be because people still on treatment had worse disease status or had more serious conditions. In our study, longer duration was associated with much worse SRH for diabetes and hypertension, and this may be because longer duration of diabetes and hypertension was associated with higher risks of complications, cardiovascular and cerebrovascular diseases \[[@CR33]--[@CR35]\]. In addition, the number of comorbidities was significantly associated with worse SRH, which is in line with the literature \[[@CR14], [@CR15], [@CR36]\]. People with more diseases have increased possibility of dysfunction and suffer more pain and inconvenience both physically and mentally, which can lead them to rate their health more negatively.

The major strength of our study is that we have covered a wide range of diseases and the analysis was based on a large population sample of both men and women in ten regions of China. We also included both global and age-comparative SRH measures in our study, and the large sample size allowed us to conduct stratified analyses with sufficient power. Many of the previous studies have only studied the contribution of diseases on global SRH at individual level, whereas we studied the contribution of diseases on both global and age-comparative SRH at both the individual and population level. However, the study has several limitations that should be noted. The main limitation is the cross-sectional design of the study, which does not allow for investigating the temporal associations between various diseases and SRH. Another limitation is that most of the studied diseases were self-reported which may be subject to misclassifications. The sensitivity analysis of using self-reported hypertension and diabetes vs. the main analysis of using both self-reported and screening-detected cases indicated that this type of misclassification might overestimate the association. This is probably because people with self-reported physician-diagnosed diseases were more likely to be severe cases, and thus the association would be attenuated if we included both self-reported and undiagnosed diseases in the analysis. However, the magnitude of attenuation may depend on the proportion of undiagnosed cases. For hypertension and diabetes, the proportion of undiagnosed cases was not negligible, in other words, the awareness of the disease was not very high in the Chinese populations \[[@CR37], [@CR38]\]. While for other diseases (such as heart diseases, stroke, cancer etc.), the proportion might be very high and the influence of the undiagnosed diseases would not substantially change our conclusions. In addition, although we have adjusted for a wide range of confounding factors such as socioeconomic, demographic and behavioral variables, residual and unmeasured confounding is still possible. For example, functional ability and/or cognitive levels, which have been previously found to be associated with SRH \[[@CR3], [@CR15], [@CR39]\], were not available in our study. Finally, detailed information on treatment and severity status of each disease was not available and more studies are still needed to examine strategies to promote better SRH among people with certain diseases.

Conclusions {#Sec10}
===========

We found chronic physical diseases (such as cardiovascular disease, diabetes, cancer) and mental illnesses are major determinants of poor global SRH and worse age-comparative SRH. Cardiometabolic diseases (hypertension, diabetes, CHD and stroke) had the strongest impact on both global SRH and age-comparative SRH at the population level. Our study suggests that prevention measures concentrated on these conditions would have the largest effect on the total burden of poor SRH and its consequences such as poor quality of life and use of health care services. Knowledge of diseases that have a great impact on both global SRH and age-comparative SRH might help in exploring the factors behind low SRH status. Knowing the patient's SRH status and the common determinants of SRH could help health professionals in the health care sectors to focus on the patient's own goals for health and function.

Appendix {#Sec11}
========

Table 5Multiple comorbidities associated with global self-rated health stratified by residential location and sexAdministrative region*P* for interactionSex*P* for interactionRuralUrbanMaleFemaleOR95% CIOR95% CIOR95% CIOR95% CICardiometabolic diseases Coronary heart disease2.752.55, 2.962.342.22, 2.46\< 0.0012.572.41, 2.752.502.37, 2.640.12 Rheumatic heart disease3.632.82, 4.672.622.03, 3.370.074.412.99, 6.492.862.33, 3.500.07 Stroke2.922.67, 3.202.692.50, 2.890.023.162.93, 3.402.692.46, 2.930.23 Hypertension1.151.13, 1.171.221.20, 1.250.0061.241.22, 1.271.241.22, 1.270.01 Diabetes1.641.57, 1.711.831.77, 1.900.0071.901.82, 1.981.691.63, 1.750.006Respiratory diseases Tuberculosis1.601.48, 1.731.371.28, 1.47\< 0.0011.551.45, 1.661.401.30, 1.510.31 Emphysema/bronchitis2.872.71, 3.051.811.70, 1.92\< 0.0012.492.34, 2.642.452.31, 2.600.99 Asthma1.891.63, 2.202.161.93, 2.410.692.051.78, 2.352.051.81, 2.310.81Musculoskeletal diseases Fracture1.091.06, 1.131.010.98, 1.04\< 0.0011.091.05, 1.121.101.07, 1.140.88 Rheumatoid arthritis1.821.70, 1.941.911.80, 2.030.801.711.58, 1.851.871.77, 1.970.008Mental diseases Depressive Symptoms2.502.24, 2.782.492.16, 2.890.532.602.22, 3.052.702.44, 3.000.98 Psychiatric disorders1.941.68, 2.241.881.62, 2.190.682.401.97, 2.932.041.79, 2.310.10 Neurasthenia2.001.82, 2.191.911.75, 2.070.221.901.70, 2.132.232.07, 2.410.005Digestive diseases Cirrhosis/chronic hepatitis1.561.45, 1.681.891.74, 2.06\< 0.0011.701.59, 1.831.581.45, 1.730.07 Peptic ulcer1.801.72, 1.891.611.55, 1.68\< 0.0011.571.50, 1.631.891.80, 1.99\< 0.001 Gallstone/gallbladder disease1.571.51, 1.621.371.32, 1.42\< 0.0011.521.45, 1.601.611.56, 1.660.004Cancer2.091.81, 2.402.712.37, 3.090.012.992.54, 3.512.312.05, 2.610.02Other diseases Kidney disease1.751.63, 1.881.401.30, 1.51\< 0.0011.501.38, 1.631.721.61, 1.84\< 0.001 Head injury1.261.17, 1.371.201.11, 1.300.101.191.11, 1.281.201.09, 1.310.81*Abbreviations*: *CI* confidence intervals, *OR* odds ratioOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbidities, except for the stratified variable in the corresponding stratified analysis

Table 6Multiple comorbidities associated with global self-rated health stratified by age and educational levelAge*P* for interactionEducation level*P* for interaction30-59 yr≥ 60 yrNo formal educationPrimary schoolMiddle school or higherOR95% CIOR95% CIOR95% CIOR95% CIOR95% CICardiometabolic diseases Coronary heart disease3.032.84,3 .242.502.37, 2.64\< 0.0012.422.18, 2.702.592.40, 2.802.562.42, 2.710.79 Rheumatic heart disease3.062.47, 3.783.682.62, 5.160.553.122.12, 4.583.572.52, 5.033.012.34, 3.870.71 Stroke3.333.04, 3.652.982.77, 3.21\< 0.0013.082.68, 3.542.922.64, 3.232.942.72, 3.190.40 Hypertension1.271.25, 1.291.191.16, 1.22\< 0.0011.141.11, 1.181.211.18, 1.231.321.29, 1.34\< 0.001 Diabetes1.831.76, 1.891.711.64, 1.79\< 0.0011.701.61, 1.811.671.59, 1.751.881.81, 1.96\< 0.001Respiratory diseases Tuberculosis1.671.56, 1.791.351.25, 1.46\< 0.0011.701.46, 1.981.451.32, 1.601.471.37, 1.570.10 Emphysema/bronchitis2.662.51, 2.812.272.13, 2.42\< 0.0012.792.55, 3.042.772.57, 2.972.041.91, 2.18\< 0.001 Asthma2.161.93, 2.411.921.64, 2.250.041.861.51, 2.302.021.70, 2.422.141.89, 2.420.66Musculoskeletal diseases Fracture1.101.07, 1.131.091.05, 1.150.031.251.18, 1.311.101.05, 1.151.051.02, 1.090.06 Rheumatoid arthritis1.971.87, 2.091.581.47, 1.71\< 0.0011.831.66, 2.021.771.63, 1.921.871.75, 2.000.58Mental diseases Depressive Symptoms2.582.34, 2.842.712.20, 3.340.932.832.34, 3.422.522.17, 2.922.672.35, 3.050.55 Psychiatric disorders2.282.02, 2.581.751.40, 2.190.0022.341.90, 2.882.021.68, 2.442.241.90, 2.650.39 Neurasthenia2.422.24, 2.611.641.47, 1.83\< 0.0012.392.07, 2.762.131.89, 2.412.061.90, 2.250.72Digestive diseases Cirrhosis/chronic hepatitis1.811.70, 1.931.401.24, 1.57\< 0.0011.551.33, 1.801.671.51, 1.851.721.60, 1.860.69 Peptic ulcer1.821.76, 1.891.401.32, 1.49\< 0.0011.811.67, 1.961.741.64, 1.851.631.56, 1.700.04 Gallstone/gallbladder disease1.691.64, 1.741.401.33, 1.47\< 0.0011.641.56, 1.731.631.56, 1.711.541.48, 1.590.12Cancer2.792.46, 3.172.412.08, 2.810.0042.702.15, 3.402.452.07, 2.892.622.28, 3.010.73Other diseases Kidney disease1.701.61, 1.811.481.33, 1.64\< 0.0011.831.58, 2.131.681.52, 1.851.571.47, 1.680.16 Head injury1.211.13, 1.291.040.92, 1.180.0011.261.07, 1.481.241.12, 1.371.151.07, 1.240.49*Abbreviations*: *CI* confidence intervals, *OR* odds ratioOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbidities, except for the stratified variable in the corresponding stratified analysis

Table 7Multiple comorbidities associated with global self-rated health stratified by household incomeHousehold income, RMB*P* for interaction\< 10,00010,000--34,999≥ 35,000OR95% CIOR95% CIOR95% CICardiometabolic diseases Coronary heart disease2.512.29, 2.762.532.40, 2.682.522.30, 2.770.86 Rheumatic heart disease2.411.81, 3.193.802.91, 4.973.642.30, 5.750.09 Stroke3.242.89, 3.622.792.59, 3.012.772.41, 3.180.60 Hypertension1.191.16, 1.221.251.23, 1.281.321.28, 1.37\< 0.001 Diabetes1.711.61, 1.811.741.68, 1.801.871.77, 1.990.001Respiratory diseases Tuberculosis1.711.54, 1.891.411.32, 1.511.411.26, 1.580.01 Emphysema/bronchitis2.752.53, 2.992.392.25, 2.542.352.15, 2.560.08 Asthma1.981.62, 2.432.051.81, 2.312.111.75, 2.540.78Musculoskeletal diseases Fracture1.141.08, 1.201.081.04, 1.111.101.05, 1.150.04 Rheumatoid arthritis1.811.66, 1.971.831.72, 1.951.851.67, 2.060.65Mental diseases Depressive Symptoms2.982.56, 3.472.552.26, 2.872.271.78, 2.890.10 Psychiatric disorders2.311.91, 2.782.141.84, 2.482.081.60, 2.700.86 Neurasthenia2.001.75, 2.282.182.00, 2.372.251.97, 2.560.07Digestive diseases Cirrhosis/chronic hepatitis1.831.62, 2.061.721.59, 1.861.511.35, 1.680.008 Peptic ulcer1.921.80, 2.041.661.59, 1.741.501.40, 1.61\< 0.001 Gallstone/gallbladder disease1.711.63, 1.811.571.51, 1.621.521.45, 1.600.003Cancer1.931.62, 2.302.632.31, 3.003.923.07, 5.01\< 0.001Other diseases Kidney disease1.711.55, 1.881.621.51, 1.741.541.36, 1.730.16 Head injury1.351.21, 1.501.111.03, 1.201.171.03, 1.340.02*Abbreviations*: *CI* confidence intervals, *OR* odds ratioOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbidities, except for the stratified variable in the corresponding stratified analysis

Table 8Multiple comorbidities associated with age-comparative self-rated health stratified by residential location and sex^a^Administrative region*P* for interactionSex*P* for interactionRuralUrbanMaleFemaleOR95% CIOR95% CIOR95% CIOR95% CICardiometabolic diseases Coronary heart disease5.624.92, 6.434.203.90, 4.53\< 0.0014.964.47, 5.494.243.91, 4.600.37 Rheumatic heart disease6.964.66, 10.385.373.74, 7.720.297.064.03, 12.365.814.29, 7.860.66 Stroke9.407.98, 11.066.295.66, 6.97\< 0.00110.219.08, 11.485.504.82, 6.26\< 0.001 Hypertension1.401.35, 1.451.531.48, 1.580.0011.441.39, 1.501.491.45, 1.54\< 0.001 Diabetes2.822.61, 3.053.183.01, 3.360.303.413.17, 3.662.802.64, 2.960.07Respiratory diseases Tuberculosis2.231.95, 2.561.651.49, 1.83\< 0.0011.881.68, 2.111.821.62, 2.060.94 Emphysema/bronchitis6.355.71, 7.063.162.88, 3.46\< 0.0014.383.97, 4.824.193.81, 4.610.99 Asthma3.242.49, 4.214.303.62, 5.110.403.572.87, 4.443.592.95, 4.370.92Musculoskeletal diseases Fracture1.231.15, 1.311.231.17, 1.290.111.181.12, 1.261.161.09, 1.230.52 Rheumatoid arthritis2.762.48, 3.082.692.45, 2.960.142.372.08, 2.692.792.56, 3.040.002Mental diseases Depressive Symptoms3.452.91, 4.094.483.66, 5.480.043.773.00, 4.753.913.33, 4.590.88 Psychiatric disorders4.513.44,5.905.173.98, 6.720.325.653.93, 8.134.483.59, 5.580.29 Neurasthenia3.352.88,3.903.162.79, 3.570.252.612.19, 3.113.503.12, 3.930.001Digestive diseases Cirrhosis/chronic hepatitis3.002.61, 3.442.852.48, 3.280.963.042.68, 3.462.281.95, 2.660.004 Peptic ulcer3.152.91, 3.402.091.95, 2.23\< 0.0012.212.06, 2.372.822.61, 3.05\< 0.001 Gallstone/gallbladder disease2.372.22, 2.532.101.99, 2.22\< 0.0012.021.86, 2.192.202.09, 2.310.001Cancer5.103.98, 6.537.205.92, 8.760.078.676.62, 11.355.334.41, 6.440.007Other diseases Kidney disease2.362.11, 2.632.322.07, 2.600.982.181.91, 2.502.382.15, 2.630.09 Head injury1.591.39, 1.831.471.30, 1.660.831.451.29, 1.641.621.39, 1.880.28*Abbreviations*: *CI* confidence intervals, *OR* odds ratio^a^Participants answering "don't know" (n = 15,691) and "about the same" (n = 321,218) for the age-comparative self-rated health status question were excluded from the analysis, leaving 175,980 participants in this analysis.Odds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbidities, except for the stratified variable in the corresponding stratified analysis

Table 9Multiple comorbidities associated with age-comparative self-rated health stratified by age and educational level^a^Age*P* for interactionEducation level*P* for interaction30-59 yr≥ 60 yrNo formal educationPrimary schoolMiddle school or higherOR95%CIOR95% CIOR95% CIOR95% CICardiometabolic diseases Coronary heart disease6.555.89, 7.294.013.68, 4.38\< 0.0013.482.92, 4.145.324.68, 6.064.684.30, 5.080.03 Rheumatic heart disease6.314.55, 8.745.213.24, 8.390.565.783.05, 10.974.692.96, 7.437.715.27, 11.280.39 Stroke9.548.22, 11.077.927.07, 8.88\< 0.0018.046.33, 10.228.026.81, 9.437.967.09, 8.940.78 Hypertension1.421.38, 1.461.291.23, 1.350.071.301.24, 1.371.401.34, 1.471.571.52, 1.630.007 Diabetes3.193.01, 3.392.682.49, 2.88\< 0.0012.602.34, 2.882.792.56, 3.033.423.21, 3.63\< 0.001Respiratory diseases Tuberculosis2.342.10, 2.611.461.28, 1.66\< 0.0012.521.96, 3.251.831.56, 2.151.851.66, 2.050.03 Emphysema/bronchitis4.634.22, 5.083.673.31, 4.070.0014.373.76, 5.075.164.59, 5.813.483.14, 3.85\< 0.001 Asthma3.963.30, 4.743.182.47, 4.090.063.672.39, 5.642.631.98, 3.504.263.55, 5.130.15Musculoskeletal diseases Fracture1.181.13, 1.241.121.03, 1.220.0031.331.21, 1.461.111.03, 1.201.181.11, 1.250.38 Rheumatoid arthritis3.042.78, 3.321.981.75, 2.24\< 0.0012.422.06, 2.852.672.35, 3.042.812.54, 3.100.67Mental diseases Depressive Symptoms4.013.46, 4.653.132.33, 4.220.023.662.70, 4.953.622.83, 4.614.173.48, 5.010.25 Psychiatric disorders5.684.53, 7.113.462.39, 5.010.0024.342.97, 6.353.882.80, 5.385.824.37, 7.770.07 Neurasthenia4.073.61, 4.581.891.59, 2.25\< 0.0013.712.85, 4.852.942.43, 3.573.252.88, 3.670.45Digestive diseases Cirrhosis/chronic hepatitis3.162.82, 3.552.131.75, 2.60\< 0.0012.682.00, 3.592.862.36, 3.482.712.39, 3.070.80 Peptic ulcer2.742.57, 2.911.851.67, 2.04\< 0.0012.702.34, 3.102.572.34, 2.832.402.24, 2.560.07 Gallstone/gallbladder disease2.372.25, 2.501.681.55, 1.82\< 0.0012.262.05, 2.482.172.00, 2.362.142.01, 2.270.04Cancer7.696.19, 9.565.384.28, 6.760.0024.483.13, 6.416.965.19, 9.347.165.80, 8.850.04Other diseases Kidney disease2.492.27, 2.731.921.63, 2.26\< 0.0012.071.64, 2.612.191.89, 2.552.402.17, 2.660.35 Head injury1.541.39, 1.711.441.16, 1.770.061.701.29, 2.221.651.39, 1.961.421.26, 1.600.42*Abbreviations*: *CI* confidence intervals, *OR* odds ratio^a^Participants answering "don't know" (*n* = 15,691) and "about the same" (*n* = 321,218) for the age-comparative self-rated health status question were excluded from the analysis, leaving 175,980 participants in this analysisOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbidities, except for the stratified variable in the corresponding stratified analysis

Table 10Multiple comorbidities associated with age-comparative self-rated health stratified by household income^a^Household income, RMB*P* for interaction\< 10,00010,000--34,999≥ 35,000OR95% CIOR95% CIOR95% CICardiometabolic diseases Coronary heart disease4.473.88, 5.164.564.20, 4.964.363.77, 5.040.37 Rheumatic heart disease4.613.07, 6.926.334.30, 9.3014.136.12, 32.620.08 Stroke8.327.00, 9.887.326.53, 8.217.295.87, 9.050.97 Hypertension1.351.29, 1.411.501.45, 1.551.691.58, 1.79\< 0.001 Diabetes2.672.44, 2.913.042.87, 3.233.413.07, 3.78\< 0.001Respiratory diseases Tuberculosis2.402.05, 2.811.711.52, 1.911.681.38, 2.04\< 0.001 Emphysema/bronchitis4.604.07, 5.204.223.83, 4.653.893.35, 4.510.04 Asthma2.782.05, 3.773.823.14, 4.654.193.08, 5.710.19Musculoskeletal diseases Fracture1.191.09, 1.301.171.11, 1.241.181.08, 1.290.69 Rheumatoid arthritis2.362.08, 2.682.902.62, 3.202.582.17, 3.070.06Mental diseases Depressive Symptoms4.123.33, 5.103.643.02, 4.394.162.84, 6.070.72 Psychiatric disorders4.323.17, 5.884.863.72, 6.366.754.07, 11.180.15 Neurasthenia2.792.28, 3.413.322.92, 3.773.552.89, 4.360.06Digestive diseases Cirrhosis/chronic hepatitis2.502.08, 2.992.882.51, 3.322.812.26, 3.490.57 Peptic ulcer2.722.47, 3.002.422.26, 2.602.231.98, 2.510.04 Gallstone/gallbladder disease2.262.09, 2.452.091.96, 2.212.312.10, 2.530.03Cancer5.303.98, 7.086.215.05, 7.6310.327.03, 15.150.02Other diseases Kidney disease2.071.81, 2.372.482.21, 2.782.311.89, 2.820.31 Head injury1.561.32, 1.841.541.35, 1.751.361.08, 1.710.71*Abbreviations*: *CI* confidence intervals, *OR* odds ratio^a^Participants answering "don't know" (*n* = 15,691) and "about the same" (n = 321,218) for the age-comparative self-rated health status question were excluded from the analysis, leaving 175,980 participants in this analysisOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbidities, except for the stratified variable in the corresponding stratified analysis

Table 11Multiple comorbidities associated with age-comparative self-rated health status: multinomial logistic regression analysis using "better" as the reference group^a^BetterAbout the sameWorseOROR95% CIOR95% CICardiometabolic diseases Coronary heart disease11.651.56, 1.754.444.17, 4.72 Rheumatic heart disease11.521.17, 1.985.974.59, 7.76 Stroke11.801.66, 1.967.426.82, 8.07 Hypertension11.181.16, 1.201.481.45, 1.51 Diabetes11.441.39, 1.502.992.87, 3.12Respiratory diseases Tuberculosis11.171.09, 1.251.891.75, 2.04 Emphysema/bronchitis11.491.40, 1.584.354.07, 4.64 Asthma11.361.19, 1.563.432.98, 3.94Musculoskeletal diseases Fracture10.990.96, 1.021.181.14, 1.23 Rheumatoid arthritis11.261.18, 1.342.652.48, 2.84Mental diseases Depressive Symptoms11.060.94, 1.213.713.26, 4.21 Psychiatric disorders11.801.51, 2.164.723.93, 5.67 Neurasthenia11.351.24, 1.473.222.94, 3.54Digestive diseases Cirrhosis/chronic hepatitis11.331.22, 1.452.632.39, 2.89 Peptic ulcer11.361.30, 1.422.482.36, 2.61 Gallstone/gallbladder disease11.301.26, 1.352.162.07, 2.25Cancer11.641.41, 1.906.445.54, 7.49Other diseases Kidney disease11.271.18, 1.362.362.19, 2.55 Head injury11.030.96, 1.111.531.40, 1.67*Abbreviations*: *CI* confidence intervals, *OR* odds ratio^a^Participants answering "don't know" (*n* = 15,691) for the age-comparative self-rated health status question were excluded from the analysis, leaving 497,198 participants in this analysisOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbidities

Table 12Multiple comorbidities associated with age-comparative self-rated health status: multinomial logistic regression analysis using "about the same" as the reference group^a^About the sameBetterWorseOROR95% CIOR95% CICardiometabolic diseases Coronary heart disease10.610.57, 0.642.692.59, 2.80 Rheumatic heart disease10.660.51, 0.853.923.38, 4.55 Stroke10.560.51, 0.604.123.92, 4.33 Hypertension10.850.83, 0.861.251.23, 1.28 Diabetes10.700.67, 0.722.082.02, 2.14Respiratory diseases Tuberculosis10.860.80, 0.921.621.53, 1.72 Emphysema/bronchitis10.670.63, 0.722.932.81, 3.05 Asthma10.740.64, 0.842.522.30, 2.75Musculoskeletal diseases Fracture11.010.98, 1.041.191.15, 1.23 Rheumatoid arthritis10.790.75, 0.842.102.00, 2.21Mental diseases Depressive Symptoms10.940.83, 1.073.493.22, 3.78 Psychiatric disorders10.560.46, 0.662.622.36, 2.91 Neurasthenia10.740.68, 0.812.392.25, 2.55Digestive diseases Cirrhosis/chronic hepatitis10.750.69, 0.821.971.85, 2.10 Peptic ulcer10.740.71, 0.771.831.76, 1.90 Gallstone/gallbladder disease10.770.74, 0.801.611.61, 1.71Cancer10.610.53, 0.713.933.60, 4.29Other diseases Kidney disease10.790.74, 0.851.861.76, 1.97 Head injury10.970.90, 1.051.491.39, 1.60*Abbreviations*: *CI* confidence intervals, *OR* odds ratio^a^Participants answering "don't know" (*n* = 15,691) for the age-comparative self-rated health status question were excluded from the analysis, leaving 497,198 participants in this analysisOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbidities

Table 13Treatment associated with self-rated health statusGlobal SRH (Total *n* = 512,889)Age-comparative SRH (Total *n* = 175,980)OR95% CIOR95% CICardiometabolic diseases Coronary heart disease  Yes, but no treatment now1.851.75, 1.962.792.55, 3.06  Yes, still on treatment2.912.73, 3.095.324.85, 5.83 Rheumatic heart disease  Yes, but no treatment now2.271.84, 2.803.672.68, 5.05  Yes, still on treatment7.335.01, 10.7219.2710.65, 34.87 Stroke  Yes, but no treatment now2.121.96, 2.284.253.78, 4.77  Yes, still on treatment3.112.85, 3.399.538.27, 10.98 Hypertension  Yes, but no treatment now1.111.09, 1.121.161.13, 1.19  Yes, still on treatment1.931.89, 1.983.383.24, 3.53 Diabetes  Yes, but no treatment now1.231.19, 1.271.511.42, 1.60  Yes, still on treatment (No insulin)2.882.75, 3.036.516.00, 7.06  Yes, still on treatment (Use insulin)3.813.36, 4.3210.018.24, 12.16Respiratory diseases TB  Yes, but no treatment now1.441.37, 1.521.821.67, 1.98  Yes, still on treatment3.252.42, 4.367.534.49, 12.62 Emphysema/bronchitis  Yes, but no treatment now2.081.98, 2.183.343.09, 3.62  Yes, still on treatment4.023.69, 4.388.107.08, 9.26 Asthma  Yes, but no treatment now1.591.43, 1.772.422.02, 2.89  Yes, still on treatment3.693.06, 4.468.216.14, 10.97Musculoskeletal diseases Fracture  Yes, but no treatment now1.101.07, 1.121.181.13, 1.23  Yes, still on treatment1.271.13, 1.431.751.43, 2.13 Rheumatoid arthritis  Yes, but no treatment now1.631.54, 1.712.192.02, 2.38  Yes, still on treatment2.642.40, 2.904.904.23, 5.67Mental diseases Psychiatric disorders  Yes, but no treatment now1.721.50, 1.973.342.64, 4.23  Yes, still on treatment3.002.53, 3.568.956.40, 12.52 Neurasthenia  Yes, but no treatment now1.901.77, 2.032.692.42, 2.99  Yes, still on treatment3.492.99, 4.076.935.39, 8.90Digestive diseases Cirrhosis/chronic hepatitis  Yes, but no treatment now1.531.44, 1.622.252.02, 2.50  Yes, still on treatment3.923.25, 4.7313.289.25, 19.06 Peptic ulcer  Yes, but no treatment now1.521.47, 1.582.081.97, 2.20  Yes, still on treatment2.822.61, 3.055.574.90, 6.32 Gallstone/gallbladder disease  Yes, but no treatment now1.511.47, 1.562.031.94, 2.13  Yes, still on treatment2.091.95, 2.243.222.87, 3.60 Cancer  Yes, but no treatment now2.161.94, 2.405.704.80, 6.78  Yes, still on treatment5.304.20, 6.6813.729.48, 19.86Other diseases Kidney disease  Yes, but no treatment now1.441.36, 1.521.931.77, 2.11  Yes, still on treatment3.212.76, 3.744.803.85, 5.98 Head injury  Yes, but no treatment now1.171.11, 1.241.491.35, 1.63  Yes, still on treatment2.271.62, 3.177.724.08, 14.62*Abbreviations*: *CI* confidence intervals, *OR* odds ratioThe reference group are those who not suffering from the diseaseOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbiditiesDepressive Symptoms is not presented because the diseases is diagnosed on this investigation

Table 14Disease diagnosis time associated with self-rated health statusGlobal SRH (Total *n* = 512,889)Age-comparative SRH (Total *n* = 175,980)OR95% CIOR95% CICardiometabolic diseases Coronary heart disease  Yes, diagnosis time \< 10 years2.672.53, 2.815.074.69, 5.49  Yes, diagnosis time ≥ 10 years2.021.88, 2.172.832.54, 3.15 Rheumatic heart disease  Yes, diagnosis time \< 10 years4.313.03, 6.139.715.63, 16.75  Yes, diagnosis time ≥ 10 years2.882.34, 3.555.283.88, 7.19 Stroke  Yes, diagnosis time \< 10 years3.082.89, 3.297.997.25, 8.82  Yes, diagnosis time ≥ 10 years1.891.67, 2.144.513.75, 5.43 Hypertension  Yes, diagnosis time \< 10 years1.211.19, 1.221.391.35, 1.42  Yes, diagnosis time ≥ 10 years1.891.82, 1.973.042.85, 3.25 Diabetes  Yes, diagnosis time \< 10 years1.671.62, 1.712.712.59, 2.84  Yes, diagnosis time ≥ 10 years2.992.72, 3.296.695.77, 7.76Respiratory diseases TB  Yes, diagnosis time \< 10 years2.221.97, 2.503.943.20, 4.84  Yes, diagnosis time ≥ 10 years1.351.28, 1.431.611.47, 1.76 Emphysema/bronchitis  Yes, diagnosis time \< 10 years2.782.60, 2.975.334.79, 5.93  Yes, diagnosis time ≥ 10 years2.282.16, 2.413.693.38, 4.02 Asthma  Yes, diagnosis time \< 10 years2.572.16, 3.074.123.18, 5.34  Yes, diagnosis time ≥ 10 years1.891.70, 2.103.432.87, 4.09Musculoskeletal diseases Fracture Yes, diagnosis time \< 10 years1.121.09, 1.161.251.19, 1.33  Yes, diagnosis time ≥ 10 years1.081.05, 1.121.131.06, 1.19 Rheumatoid arthritis  Yes, diagnosis time \< 10 years1.841.75, 1.922.702.51, 2.90Mental diseases Psychiatric disorders  Yes, diagnosis time \< 10 years2.542.12, 3.056.914.86, 9.81  Yes, diagnosis time ≥ 10 years1.991.75, 2.274.203.35, 5.26 Neurasthenia  Yes, diagnosis time \< 10 years2.732.43, 3.064.874.08, 5.82  Yes, diagnosis time ≥ 10 years1.911.78, 2.062.642.36, 2.97Digestive diseases Cirrhosis/chronic hepatitis  Yes, diagnosis time \< 10 years2.101.91, 2.323.953.32, 4.68  Yes, diagnosis time ≥ 10 years1.491.39, 1.602.231.97, 2.52 Peptic ulcer  Yes, diagnosis time \< 10 years1.961.87, 2.063.293.04, 3.57  Yes, diagnosis time ≥ 10 years1.511.45, 1.572.031.90, 2.17 Gallstone/gallbladder disease  Yes, diagnosis time \< 10 years1.661.61, 1.712.362.23, 2.48  Yes, diagnosis time ≥ 10 years1.461.40, 1.521.881.76, 2.01 Cancer  Yes, diagnosis time \< 10 years3.062.72, 3.458.607.05, 10.48  Yes, diagnosis time ≥ 10 years1.761.49, 2.083.572.76, 4.61Other diseases Kidney disease  Yes, diagnosis time \< 10 years1.751.64, 1.872.362.14, 2.61  Yes, diagnosis time ≥ 10 years1.441.33, 1.562.131.87, 2.43 Head injury  Yes, diagnosis time \< 10 years1.231.13, 1.341.561.35, 1.80  Yes, diagnosis time ≥ 10 years1.161.08, 1.251.521.35, 1.72*Abbreviations*: *CI* confidence intervals, *OR* odds ratioThe reference group are those who not suffering from the diseaseOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbiditiesDepressive Symptoms is not presented because the disease is diagnosed on this investigation

Table 15The number of diseases associated with self-rated health statusGlobal SRH (Total *n* = 512,889)Age-comparative SRH (Total n = 175,980)OR95% CIOR95% CINumber of diseases One disease1.441.42, 1.462.132.07, 2.18 Two diseases2.372.32, 2.425.154.98, 5.33 Three diseases3.913.76, 4.0710.509.88, 11.16 Four or more diseases6.455.96, 6.9820.3918.30, 22.71*Abbreviations*: *CI* confidence intervals, *OR* odds ratioThe reference group are those who not suffering from the diseaseOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI and family history of five diseases (stroke, heart attack, diabetes, mental disorders and cancer)

Table 16The site of cancer associated with self-rated health statusGlobal SRH (Total *n* = 512,889)Age-comparative SRH (Total *n* = 175,980)OR95% CIOR95% CICancer site lung3.382.15, 5.338.314.08, 16.96 esophagus2.261.71, 3.008.945.43, 14.74 stomach2.942.17, 4.007.794.72, 12.86 liver3.851.48, 10.017.152.28, 22.41 intestine2.351.78, 3.105.663.59, 8.94 breast2.311.90, 2.815.944.34, 8.14 cervix2.301.78, 2.993.702.45, 5.59 other2.942.40, 3.617.385.41, 10.07*Abbreviations*: *CI* confidence intervals, *OR* odds ratioThe reference group are those who not suffering from this cancerOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five disease (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbidities

Table 17Multiple comorbidities associated with global and age-comparative self-rated health status: sensitivity analysis of using self-reported hypertension and diabetesGlobal SRH\
(Total *n* = 512,889)Age-comparative SRH (Total *n* = 175,980)OR95% CIOR95% CIMain analysis Hypertension1.251.23, 1.261.471.44, 1.51 Diabetes1.771.72, 1.823.032.89, 3.16Sensitivity analysis Hypertension1.831.79, 1.863.082.97, 3.20 Diabetes2.802.69, 2.926.075.67, 6.50*Abbreviations*: *CI* confidence intervals, *OR* odds ratioOdds ratios (95% CI) were calculated after adjustment of age, sex, study location, marital status, household income, education level, occupation, alcohol drinking, cigarette smoking, physical activity, BMI, family history of five disease (stroke, heart attack, diabetes, mental disorders and cancer) and all comorbidities

BMI

:   Body mass index

CHD

:   Coronary heart disease

CI

:   Confidence intervals

CIDI-SF

:   Composite International Diagnostic Inventory --- short form

CKB

:   China Kadoorie Biobank

METs

:   Metabolic equivalent tasks

OR

:   Odds ratio

PARs

:   Population attributable risks

SRH

:   Self-rated health
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